Edgen Stock·Oct 22 2025, 17:24Back
Back
Takeda Forms Strategic Oncology Collaboration to Bolster Future Pipeline
Edgen Stock·Oct 22 2025, 17:24
[1] Takeda Pharmaceutical Company Limited (TAK) Discusses Global Strategic Collaboration for Next-Generation Oncology Assets and ADC Molecules - Slideshow[2] Innovent Biologics and Takeda Pharmaceutical Collaboration Details[3] Takeda Enters Global Strategic Partnership with Innovent Biologics to Bolster Oncology Pipeline with Next-Generation Investigational Medicines for Treatment of Solid Tumors – Company Announcement - Markets data